Distinct oligoclonal t cells are associated with graft versus host disease after stem-cell transplantation

Transplantation

Volumn 93, Issue 9, 2012, Pages 949-957

  Berrie, Jennifer L ^a   Kmieciak, MacIej ^a   Sabo, Roy T ^a   Roberts, Catherine H ^a   Idowu, Michael O ^a   Mallory, Katherine ^a   Chung, Harold M ^a   McCarty, John M ^a   Borrelli, Christian A ^b   Detwiler, Michelle M ^b   Kazim, A Latif ^b   Toor, Amir A ^a   Manjili, Masoud H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Graft versus host disease; Graft versus tumor effects; Stem cell transplantation; T cell oligoclonality

Indexed keywords

T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR 11; T LYMPHOCYTE RECEPTOR 12; T LYMPHOCYTE RECEPTOR 15; T LYMPHOCYTE RECEPTOR 16; T LYMPHOCYTE RECEPTOR 17; T LYMPHOCYTE RECEPTOR 20; T LYMPHOCYTE RECEPTOR 23; T LYMPHOCYTE RECEPTOR 3; T LYMPHOCYTE RECEPTOR 7; T LYMPHOCYTE RECEPTOR VBETA2; T LYMPHOCYTE RECEPTOR VBETA4; T LYMPHOCYTE RECEPTOR VBETA9; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DONOR SELECTION; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS TUMOR REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE CLONE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTRATYPING ANALYSIS; SPECTROSCOPY; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ADULT; AGED; DNA; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 84860736604     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182497561     Document Type: Article

References (34)

1. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555.
2. Ringden O, Pavletic SZ, Anasetti C, et al. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLAidentical siblings for hematopoietic stem cell transplantation. Blood 1990; 113: 3110.
3. Collins R, Shpilberg O, Drobyski W, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433.
4. Simula MP, Marktel S, Fozza C, et al. Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: The importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia 2007; 21: 943.
5. Baron F, Maris MB, Sandmaier BM, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol 2005; 23: 1993.
6. Valcarcel D, Sierra J, Wang T, et al. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biol Blood Marrow Transplant 2011; 17: 640.
7. Toor A, Rodriguez T, Bauml M, et al. Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT. Bone Marrow Transplant 2008; 42: 723.
8. Ofran Y, Ritz J. Targets of tumor immunity after allogeneic hematopoietic stem cell transplantation. Clin Cancer Res 2008; 14: 4997.
9. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340.
10. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281.
11. Spellman S, Warden MB, Haagenson M, et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLAmatched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant 2009; 15: 856.
12. Marijt W, Heemskerk M, Kloosterboer F, et al. Hematopoiesisrestricted minor histocompatibility antigens HA-1-or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742.
13. Ochi T, Fujiwara H, Yasukawa A. Application of adoptive t-cell therapy using tumor antigen-specific t-cell receptor gene transfer for the treatment of human leukemia. J Biomed Biotechnol 2010; 2010: 521248.
14. Mullally A, Ritz J. Beyond HLA. The significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355.
15. Miller JS, Warren EH, van den Brink MR, et al. NCI First International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-tumor/leukemia reaction. Biol Blood Marrow Transplant 2010; 16: 565.
16. Hirokawa M, Matsutani T, SaitohH, et al. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 915.
17. Liu C, He M, Rooney B, et al. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 335.
18. Du J, Gu J, Liu J, et al. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2007; 48:1618.
19. Beck R, Wlodarski M, Gondek L, et al. Efficient identification of T-cell clones associated with graft-versus-host disease in target tissue allows for subsequent detection in peripheral blood. Br J Haematol 2005; 129: 411.
20. Zeiser R, Marks R, Bertz H, et al. Immunopathogenesis of acute graftversus-host disease: Implications for novel preventive and therapeutic strategies. Ann Hematol 2004; 83:551565.
21. Barrett AJ. Understanding and harnessing the graft-versus-leukaemia effect. Br J Haematol 2008; 142: 877.
22. van Besien K, Dew A, Lin S, et al. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: Mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymphoma 2009; 50: 1809.
23. Stern M, Brand R, de Witte T, et al. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant 2008; 8: 2149.
24. Kamei M, Nannya Y, Torikai H, et al.HapMap scanning of novel human minor histocompatibility antigens. Blood 2009; 113: 5041.
25. Goulmy E. Minor histocompatibility antigens: Allo target molecules for tumor-specific immunotherapy. Cancer J 2004; 10: 1.
26. DeLuca DS, Eiz-Vesper B, Ladas N, et al. High-throughput minor histocompatibility antigen prediction. Bioinformatics 2000; 25: 2411.
27. Matte-Martone C, Liu J, Jain D, et al. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL. Blood 2008; 111: 3884.
28. Spierings E, Hendriks M, Absi L, et al. Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007; 3: e103.
29. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945.
30. Thor Straten P, Ralfkiaer E, Hendriks J, et al. T-cell receptor variable region genes in cutaneous T-cell lymphomas. Br J Dermatol 1998; 138: 3.
31. Pikor LA, Enfield KS, Cameron H, et al. DNA extraction from paraffin embedded material for genetic and epigenetic analyses. J Vis Exp 2011; (49): pii: 2763.
32. Ashby D, Hutton J, McGee M. Simple Bayesian analyses for casecontrol studies in cancer-epidemiology. Statistician 1993; 42: 385.
33. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation. London: John Wiley & Sons, Ltd; 2004.
34. Carlin BP, Louis TA. Bayes and empirical Bayes methods for data analysis, ed. 4. New York: Chapman & Hall/CRC; 2000.